Rice University

Other · Houston, Texas

Rice University is a university based in Houston, Texas. 9 portfolio companies are on record.

AUM
—
Portfolio companies
9
Recorded deals
—
Last investment
—

Rice University key facts

  • Rice University is a other based in Houston, Texas with 9 tracked portfolio companies.
  • Notable positions include AgZen, Helix Earth, OncoResponse.
  • The team roster lists 11 people.

About Rice University

Rice University is a university based in Houston, Texas. Established in 1912, the university is a comprehensive research university that fosters diversity and an intellectual environment. The assets are managed by the executive management team.

Rice University portfolio at a glance

9 portfolio companies are on record for Rice University, including AgZen, Helix Earth and OncoResponse.

6 of the 9 carry a recorded valuation.

Rice University team

11 people are on record at Rice University. Senior names include Adrian Tromel (Executive), Bart Broadman (Trustee) and Brad Fralic (Assistant Vice President). 11 of them have a verified direct contact on file.

Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.

Free account
See more of the book
  • ·The top 10 names in the book — of 9 recorded positions
  • ·Watchlist + alerts for Rice University's activity
Create free account

Membership and data by Private Market View

No card required

Portfolio

9 companies · priced for members
CompanyValuationRole
AgZen▮▮
Helix Earth▮▮
OncoResponse▮▮
+ 6 more companies · all 9, priced and dated
or a free account shows the top 10 names — no card
The whole book · Pro $99 a month

Membership and data by Private Market View

Team
11 people on record — 11 with verified contacts

Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.

See the team →

Frequently asked about Rice University

What companies does Rice University invest in?
Rice University has 9 recorded portfolio companies, including AgZen, Helix Earth, OncoResponse.